Medicare Enrolled

Dr. Daniel Jacobs, M.D.

Neurology · Orlando, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3849 OAKWATER CIRCLE, Orlando, FL 32806
4072401762
Registered in NPPES since 2005
NPI: 1356323166 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jacobs from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jacobs? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jacobs

Dr. Daniel Jacobs is a neurology specialist in Orlando, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Jacobs performed 15,986 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Jacobs received a total of $28,718 from 86 pharmaceutical and/or device companies across 1452 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jacobs is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 7% volume in FL $28,718 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 63521 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
15,986
Medicare services
Top 7% in FL for neurology
Not available
Unique patients (not deduplicated)
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Ocrelizumab infusion (Ocrevus) for MS 14,400 $43 $162
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
670 $132 $302
New patient office visit, complex (60-74 min) 125 $164 $434
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
119 $16 $110
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
113 $75 $175
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
99 $12 $68
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
93 $94 $600
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
76 $94 $225
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
72 $49 $210
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
51 $4 $20
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
49 $1 $2
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
44 $21 $130
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
32 $334 $550
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
24 $135 $300
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
19 $163 $450
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
91.9% high complexity
1.7% medium
6.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$28,718
Total received (2018-2024)
Avg $4,103/year across 7 years
Top 12% in FL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
1,452
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,301
2023
$7,524
2022
$5,453
2021
$3,641
2020
$3,573
2019
$3,389
2018
$1,837

Payments by company (2024)

ACADIA Pharmaceuticals Inc
$344
Amgen Inc.
$276
ABBVIE INC.
$242
Genentech USA, Inc.
$222
TG Therapeutics, Inc.
$217
Vanda Pharmaceuticals Inc.
$172
EMD Serono, Inc.
$172
PFIZER INC.
$169
Biogen, Inc.
$166
BIOTRONIK INC.
$139
JAZZ PHARMACEUTICALS INC.
$111
UCB, Inc.
$104
ARGENX US, INC.
$103
Lilly USA, LLC
$84
Alexion Pharmaceuticals, Inc.
$77
ANI Pharmaceuticals, Inc.
$69
Eisai Inc.
$68
Novartis Pharmaceuticals Corporation
$61
Takeda Pharmaceuticals U.S.A., Inc.
$57
Amneal Pharmaceuticals LLC
$56
Grifols USA, LLC
$47
Merz Pharmaceuticals, LLC
$45
AstraZeneca Pharmaceuticals LP
$43
CATALYST PHARMACEUTICALS, INC.
$36
MDD US Operations, LLC
$35
Lundbeck LLC
$32
Neurocrine Biosciences, Inc.
$29
REVANCE THERAPEUTICS, INC.
$25
Avadel CNS Pharmaceuticals, LLC
$24
Inspire Medical Systems, Inc.
$22
Harmony Biosciences Llc
$20
Celgene Corporation
$18
HARMONY BIOSCIENCES LLC
$16
Top 3 companies account for 26.1% of 2024 payments
All-time payments by company (2018-2024) ›
ARGENX US, INC.
$3,347
GENZYME CORPORATION
$1,990
Horizon Therapeutics plc
$1,804
ACADIA Pharmaceuticals Inc
$1,473
Biogen, Inc.
$1,440
Genentech USA, Inc.
$1,265
Novartis Pharmaceuticals Corporation
$1,258
ABBVIE INC.
$1,142
EMD Serono, Inc.
$1,043
Teva Pharmaceuticals USA, Inc.
$954
Allergan, Inc.
$928
Banner Life Sciences, LLC
$867
Alexion Pharmaceuticals, Inc.
$750
Amgen Inc.
$747
Lilly USA, LLC
$720
UCB, Inc.
$712
Harmony Biosciences LLC
$548
JAZZ PHARMACEUTICALS INC.
$532
Sunovion Pharmaceuticals Inc.
$370
TG THERAPEUTICS, INC.
$329
Celgene Corporation
$327
PFIZER INC.
$294
Allergan Inc.
$267
Amneal Pharmaceuticals LLC
$265
US WorldMeds, LLC
$234
AbbVie Inc.
$228
Takeda Pharmaceuticals U.S.A., Inc.
$218
TG Therapeutics, Inc.
$217
CSL Behring
$205
Acorda Therapeutics, Inc
$197
GE HEALTHCARE
$186
Eisai Inc.
$182
CATALYST PHARMACEUTICALS, INC.
$178
Grifols USA, LLC
$175
Vanda Pharmaceuticals Inc.
$172
Neurocrine Biosciences, Inc.
$169
Supernus Pharmaceuticals, Inc.
$165
Janssen Pharmaceuticals, Inc
$159
ANI Pharmaceuticals, Inc.
$155
Mallinckrodt Enterprises LLC
$151
Alnylam Pharmaceuticals Inc.
$147
Lundbeck LLC
$146
BIOTRONIK INC.
$139
Biohaven Pharmaceutical Holding Company Ltd.
$104
BANNER LIFE SCIENCES, LLC
$96
Corium, LLC
$88
Jazz Pharmaceuticals Inc.
$85
UPSHER-SMITH LABORATORIES LLC
$80
Adamas Pharmaceuticals, Inc.
$79
Avadel CNS Pharmaceuticals, LLC
$76
Mallinckrodt Hospital Products Inc.
$74
Avion Pharmaceuticals
$70
MDD US Operations, LLC
$66
Merz Pharmaceuticals, LLC
$64
Upsher-Smith Laboratories LLC
$64
E.R. Squibb & Sons, L.L.C.
$60
Axsome Therapeutics, Inc.
$59
Kyowa Kirin, Inc.
$58
AstraZeneca Pharmaceuticals LP
$56
GE Healthcare
$55
Mallinckrodt LLC
$54
Boston Scientific Corporation
$47
Impax Laboratories, Inc.
$43
SANOFI-AVENTIS U.S. LLC
$40
Strongbridge US INC.
$40
Abbott Laboratories
$39
Bayer HealthCare Pharmaceuticals Inc.
$38
Otsuka America Pharmaceutical, Inc.
$36
Exeltis, USA Inc.
$32
IDORSIA PHARMACEUTICALS US INC
$29
Avanir Pharmaceuticals, Inc.
$29
REVANCE THERAPEUTICS, INC.
$25
Inspire Medical Systems, Inc.
$22
Harmony Biosciences Llc
$20
Biohaven Pharmaceuticals, Inc.
$20
MITSUBISHI TANABE PHARMA AMERICA, INC.
$20
Xeris Pharmaceuticals, Inc.
$19
Medtronic USA, Inc.
$19
Akcea Therapeutics, Inc.
$17
HARMONY BIOSCIENCES LLC
$16
Medtronic Vascular, Inc.
$15
Promius Pharma LLC
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Piramal Imaging Limited
$13
ARBOR PHARMACEUTICALS, INC.
$13
Zyla Life Sciences
$12
Top 3 companies account for 24.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BIOMONITOR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Bafiertam · Betaseron · Briviact · CINQAIR · COMIRNATY · COPAXONE · DAXXIFY · DAYBUE · DISEASE STATE · DUOPA · Dhivy · EMGALITY · Enspryng · Evrysdi · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GENERAL - DBS · GILENYA · GOCOVRI · Gamunex-C · General - DBS · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LUMRYZ · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rebif · Repatha · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · Soliris · Solitaire · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · WAKIX · Wakix · XYREM · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Orlando?
Compare neurologists in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
92
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jacobs is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Jacobs experienced with ocrelizumab infusion (ocrevus) for ms?
Based on Medicare claims data, Dr. Jacobs performed 14,400 ocrelizumab infusion (ocrevus) for ms services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jacobs receive payments from pharmaceutical companies?
Yes. Dr. Jacobs received a total of $28,718 from 86 companies across 1,452 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jacobs's costs compare to other neurologists in Orlando?
Dr. Jacobs's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jacobs) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →